A David Beckham-backed company that uses cannabis compounds to make skincare products is set to float on the London Stock Exchange. Cellular Goods has sold a stake to David Beckham’s investment vehicle, DB Ventures, as it seeks to trade on the stock market with a £20 million (€22.6 million) valuation. The company uses biosynthetic cannabinoids to make skincare and athletic recovery products. Cellular Goods is different from many competitors in the fast-growing market, by making its products in laboratories, rather than directly from plants. On Thursday morning, Cellular Goods said it intends to raise around £8 million through a retail share offering.
Mmp News Author, Medical Marijuana Program Connection, 02/05/2021 05:10:00